Cross Country Healthcare (CCRN) EBITDA: 2009-2025
Historic EBITDA for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to -$4.9 million.
- Cross Country Healthcare's EBITDA fell 29077.35% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.8 million, marking a year-over-year decrease of 79394.8%. This contributed to the annual value of -$14.6 million for FY2024, which is 12011.76% down from last year.
- Per Cross Country Healthcare's latest filing, its EBITDA stood at -$4.9 million for Q3 2025, which was down 29077.35% from -$6.7 million recorded in Q2 2025.
- In the past 5 years, Cross Country Healthcare's EBITDA ranged from a high of $77.6 million in Q4 2021 and a low of -$16.1 million during Q2 2024
- In the last 5 years, Cross Country Healthcare's EBITDA had a median value of $12.8 million in 2023 and averaged $19.2 million.
- As far as peak fluctuations go, Cross Country Healthcare's EBITDA surged by 624986.88% in 2021, and later plummeted by 29077.35% in 2025.
- Quarter analysis of 5 years shows Cross Country Healthcare's EBITDA stood at $77.6 million in 2021, then tumbled by 53.22% to $36.3 million in 2022, then tumbled by 75.08% to $9.0 million in 2023, then tumbled by 141.97% to -$3.8 million in 2024, then decreased by 27.97% to -$4.9 million in 2025.
- Its last three reported values are -$4.9 million in Q3 2025, -$6.7 million for Q2 2025, and -$485000.0 during Q1 2025.